BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37156295)

  • 21. Identification and Characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) Substrate.
    Mulvaney KM; Matson JP; Siesser PF; Tamir TY; Goldfarb D; Jacobs TM; Cloer EW; Harrison JS; Vaziri C; Cook JG; Major MB
    J Biol Chem; 2016 Nov; 291(45):23719-23733. PubMed ID: 27621311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO.
    Cleasby A; Yon J; Day PJ; Richardson C; Tickle IJ; Williams PA; Callahan JF; Carr R; Concha N; Kerns JK; Qi H; Sweitzer T; Ward P; Davies TG
    PLoS One; 2014; 9(6):e98896. PubMed ID: 24896564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Label-Free Interactome Analysis Revealed an Essential Role of CUL3-KEAP1 Complex in Mediating the Ubiquitination and Degradation of PHD2.
    Luo A; Chen Y
    J Proteome Res; 2020 Jan; 19(1):260-268. PubMed ID: 31763849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug screening assay based on the interaction of intact Keap1 and Nrf2 proteins in cancer cells.
    Zhou B; Zhang X; Wang G; Barbour KW; Berger FG; Wang Q
    Bioorg Med Chem; 2019 Jan; 27(1):92-99. PubMed ID: 30473361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New strategies to inhibit KEAP1 and the Cul3-based E3 ubiquitin ligases.
    Canning P; Bullock AN
    Biochem Soc Trans; 2014 Feb; 42(1):103-7. PubMed ID: 24450635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Cul3 binding proteins function to remodel E3 ligase complexes.
    Wimuttisuk W; West M; Davidge B; Yu K; Salomon A; Singer JD
    BMC Cell Biol; 2014 Jul; 15():28. PubMed ID: 25011449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Basis of the KEAP1-NRF2 Signaling Pathway.
    Suzuki T; Takahashi J; Yamamoto M
    Mol Cells; 2023 Mar; 46(3):133-141. PubMed ID: 36994473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of Keap1 interactions with Nrf2.
    Canning P; Sorrell FJ; Bullock AN
    Free Radic Biol Med; 2015 Nov; 88(Pt B):101-107. PubMed ID: 26057936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1.
    Eggler AL; Small E; Hannink M; Mesecar AD
    Biochem J; 2009 Jul; 422(1):171-80. PubMed ID: 19489739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sp1 is a substrate of Keap1 and regulates the activity of CRL4A
    Siswanto FM; Oguro A; Imaoka S
    J Biol Chem; 2021; 296():100704. PubMed ID: 33895141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cullin 3 mutant causing familial hyperkalemic hypertension lacks normal activity in the kidney.
    Maeoka Y; Cornelius RJ; Ferdaus MZ; Sharma A; Nguyen LT; McCormick JA
    Am J Physiol Renal Physiol; 2022 Nov; 323(5):F564-F576. PubMed ID: 36007890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants.
    Dinkova-Kostova AT; Kostov RV; Canning P
    Arch Biochem Biophys; 2017 Mar; 617():84-93. PubMed ID: 27497696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases.
    Zhuang M; Calabrese MF; Liu J; Waddell MB; Nourse A; Hammel M; Miller DJ; Walden H; Duda DM; Seyedin SN; Hoggard T; Harper JW; White KP; Schulman BA
    Mol Cell; 2009 Oct; 36(1):39-50. PubMed ID: 19818708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases.
    Pinkas DM; Sanvitale CE; Bufton JC; Sorrell FJ; Solcan N; Chalk R; Doutch J; Bullock AN
    Biochem J; 2017 Nov; 474(22):3747-3761. PubMed ID: 28963344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cullin 3 and Its Role in Tumorigenesis.
    Chen RH
    Adv Exp Med Biol; 2020; 1217():187-210. PubMed ID: 31898229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.
    Shibata T; Ohta T; Tong KI; Kokubu A; Odogawa R; Tsuta K; Asamura H; Yamamoto M; Hirohashi S
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13568-73. PubMed ID: 18757741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancer.
    Martinez VD; Vucic EA; Thu KL; Pikor LA; Lam S; Lam WL
    Head Neck; 2015 May; 37(5):727-34. PubMed ID: 24596130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CAND1 exchange factor promotes Keap1 integration into cullin 3-RING ubiquitin ligase during adipogenesis.
    Dubiel D; Ordemann J; Pratschke J; Dubiel W; Naumann M
    Int J Biochem Cell Biol; 2015 Sep; 66():95-100. PubMed ID: 26219975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62.
    Lau A; Wang XJ; Zhao F; Villeneuve NF; Wu T; Jiang T; Sun Z; White E; Zhang DD
    Mol Cell Biol; 2010 Jul; 30(13):3275-85. PubMed ID: 20421418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.